PHARMAC | A Crown Entity of New Zealand - Te Pātaka Whaioranga
News and latest updates
-
Proposal to widen access to rituximab for treatment of membranous nephropathy
widening access to more medicine for more people
04 December 2020
-
PHARMAC to fund new haemophilia medicine
Emicizumab (Hemlibra) approved for funding.
11 November 2020
-
November 2020 tender notification
Find out what tenders we've awarded.
30 November 2020
About PHARMAC | Mō Te Pātaka Whaioranga
- Our purpose is to deliver the best health outcomes from the Government’s investment in medicines and medical devices.
- We promote the responsible use of medicines in New Zealand. This means making sure medicines are not under-used, over-used or misused.
- Te Pātaka Whaioranga, ‘the storehouse of wellbeing’, sums up the part we play in managing and safeguarding something that is valuable to our whole community – the pursuit of wellbeing.
- We negotiate national contracts for hospital medical devices. In the future, we'll decide which medical devices are available for public hospitals.
Have your say on our funding decisions
We ask for your feedback on our decisions to fund a medicine or related product. We want to know what impact funding that medicine will have on prescribers, pharmacists and people who take the medicine.
Contact us
Talk to our enquiries team. We're ready to answer your questions about funded medicines and related products.
2020/21 Summer holiday
Find the deadline for funding applications and when PHARMAC is open over the summer public holiday break.